How to Use Pramipexole
The Carlat Psychiatry Report, Volume 18, Number 2, February 2020
https://www.thecarlatreport.com/newsletter-issue/tcprv18n2/
Issue Links: Learning Objectives | Editorial Information
Topics: Depression | Parkinson’s Disease | Pramipexole
Pramipexole is a selective agonist at the dopamine D3 receptor, which is thought to regulate hedonic drive. It is FDA approved in Parkinson’s disease and restless legs syndrome, and has five randomized controlled trials in depression.
You can't view details of this content, please login or buy subscription here